Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH MEDIA
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC

Agreement to Promote Development of Single-Use Biomass Sensors

By BiotechDaily International staff writers
Posted on 11 Mar 2013
A recently announced marketing and development agreement focuses on single-use biosensors that are used by the biopharmaceutical industry for obtaining in-line biomass measurements during cell cultivation and fermentation processes.

Sartorius Stedim Biothech (Aubagne, France), a leading provider of equipment and services for development, quality assurance, and production in the biopharmaceutical industry, will be cooperating with Aber Instruments (Aberystwyth, United Kingdom), a global leader in in-line biomass measurement technology. Biomass sensors are high-performance tools for modeling and optimizing biopharmaceutical development and manufacturing processes.

The agreement will give Sartorius exclusive global marketing and distribution rights to Aber's single-use sensor technology for the biopharmaceutical market. Sartorius will manufacture the biomass sensors under license, integrate these into its single-use bioreactors, and exclusively market these products in a dual-branding arrangement. New single-use sensors will be developed by both companies.

"Single-use sensors make our disposable bags even more intelligent," said Stefan Schlack, senior vice president of marketing at Sartorius Stedim Biothech. "They deliver real-time information about the progress of cell culture processes and help biopharmaceutical customers to understand their processes even better and further optimize them – a decisive competitive advantage."

Dr. John Carvell, sales and marketing director at Aber Instruments, said, "Based on Sartorius Stedim Biothech's global sales and distribution network, we can make our technology accessible to an even wider group of customers. Sartorius has in-depth expertise in single-use technology and is thoroughly versed in bioprocesses. Together with our profound knowledge of in-line biomass measurement, both companies stand to benefit from the joint development of new sensors.”

Related Links:

Sartorius Stedim Biothech
Aber Instruments




Channels

Genomics/Proteomics

view channel
Image: Cancer cells, left, were pretreated with a drug that blocks the ERK signal, and right, without the pretreatment. Top cells are untreated, while the bottom ones are stimulated (Photo courtesy of the Weizmann Institute of Science).

Prevention of ERK Nuclear Translocation Blocks Cancer Proliferation in Animal Models

A team of cell biologists has shown that the cancer promoting effects of ERK dysregulation can be blocked by low molecular weight drugs that prevent translocation of this kinase from the cells' cytoplasm... Read more

Drug Discovery

view channel
Image: Star-like glial cells in red surround alpha-beta plaques in the cortex of a mouse with a model of Alzheimer\'s disease (Photo courtesy of Strittmatter laboratory/Yale University).

Experimental Cancer Drug Reverses Symptoms in Mouse Model of Alzheimer's Disease

An experimental, but clinically disappointing drug for treatment of cancer has been found to be extremely effective in reversing the symptoms of Alzheimer's disease (AD) in a mouse model.... Read more

Biochemistry

view channel
Image:  Model depiction of a novel cellular mechanism by which regulation of cryptochromes Cry1 and Cry2 enables coordination of a protective transcriptional response to DNA damage caused by genotoxic stress (Photo courtesy of the journal eLife, March 2015, Papp SJ, Huber AL, et al.).

Two Proteins Critical for Circadian Cycles Protect Cells from Mutations

Scientists have discovered that two proteins critical for maintaining healthy day-night cycles also have an unexpected role in DNA repair and protecting cells against genetic mutations that could lead... Read more

Business

view channel

NanoString and MD Anderson Collaborate on Development of Novel Multi-Omic Expression Profiling Assays for Cancer

The University of Texas MD Anderson Cancer Center (Houston, TX, USA) and NanoString Technologies, Inc. (Seattle, WA, USA) will partner on development of a revolutionary new type of assay—simultaneously profiling gene and protein expression, initially aiming to discover and validate biomarker signatures for immuno-oncology... Read more
 

Events

21 Apr 2015 - 23 Apr 2015
21 Apr 2015 - 23 Apr 2015
Copyright © 2000-2015 Globetech Media. All rights reserved.